Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth in issues and stay up to date on the latest trends. We encourage you to subscribe to our monthly publication Policy and Medicine Compliance Update.
In our April issue we begin with a recent review of a recent Medical Information benchmarking survey. The survey examines how Medical Information functions are coping with the current digital environment.
Turning to litigation and enforcement, we start by reviewing the most recent False Claims Act (“FCA”) statistics from the Justice Department. Discounting the Purdue Pharma global settlement, the data show modest results that are in line with previous fiscal years.
Next, we examine the FCA’s whistleblower anti-retaliation protections for former employees. The recent refusal by the U.S. Supreme Court to take up a Sixth Circuit case means that the current split among the circuits will continue and likely needs Congress to resolve.
Finally we review another FCA case involving alleged kickbacks by Medtronic, the U.S. District Court held that Fair Market Value payments do not provide complete protection against kickback and false claims allegations.
Feature
Medical Information in a Digital World
A Survey of Pharmaceutical Company Approaches
By Nadja Torres and Darshan Kulkarni, Pharm. D., M.S., Esq.
Summary: The emergence of digital technologies such as websites and bots provides Medical Information...
A front-page article with the byline of veteran New York Times opinion writer Nicholas Kristof is the latest poisonous example of what I call the NGO “halo effect.” Headlined “The Silence That Mee...